Current progress in gene delivery technology based on chemical methods and nano-carriers

Theranostics

Volumn 4, Issue 3, 2014, Pages 240-255

  Jin, Lian ^a   Zeng, Xin ^b   Liu, Ming ^a   Deng, Yan ^a,c   He, Nongyue ^a,c  

^a SOUTHEAST UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c HUNAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Chemical Methods; Gene delivery; Non viral; Vectors

Indexed keywords

CHEMICAL METHODS.; GENE DELIVERY; NON-VIRAL; VECTORS;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; LIPOSOMES; NANOPARTICLES; POLYMERS;

EID: 84893570194     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.6914     Document Type: Review

References (282)

1. Gupta A, Sharma A, von Boehmer L, Surace L, Knuth A, van den Broek M. Radiotherapy supports protective tumor-specific immunity. Oncoimmunology. 2012; 1(9): 1610-1611.
2. Gajjar M, Candeias MM, Malbert-Colas L, Mazars A, Fujita J, Olivares-Illana V, Fåhraeus R. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell. 2012; 21(1): 25-35.
3. Moon EK, Son M, Jin YW, Park S, Lee WJ. Variations of Lung Cancer Risk from Asbestos Exposure: Impact on estimation of population attributable fraction. Ind Health. 2013; 51(1): 128-133.
4. Chang HJ, Ko HL, Lee CY, Wu RH, Yeh YW, Jiang JS, Kao SJ, Chi KH. Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy. Radiat Oncol. 2012; 7: 222.
5. Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013; 108(1): 179-182.
6. Gill S, Kalos M. T cell-based gene therapy of cancer. Transl Res. 2013; 161(4): 365-379.
7. Song H, Song C, Wang H, et al. Suppression of hepatocarcinoma model in vitro and in vivo by ECRG2 delivery using adenoviral vector. Cancer Gene Ther. 2012; 19(12): 875-879.
8. Mannell H, Pircher J, Fochler F, Stampnik Y, Räthel T, Gleich B, Plank C, Mykhaylyk O, Dahmani C, Wörnle M, Ribeiro A, Pohl U, Krötz F. Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles. Nanomedicine. 2012; 8(8): 1309-1318.
9. Iwashita S, Hiramatsu Y, Otani T, Amano C, Hirai M, Oie K, Yuba E, Kono K, Miyamoto M, Igarashi K. Polyamidoamine dendron-bearing lipid assemblies: Their morphologies and gene transfection ability. J Biomater Appl. 2012; 27(4): 445-456.
10. Siu YS, Li L, Leung MF, Lee KL, Li P. Polyethylenimine-based amphiphilic core-shell nanoparticles: Study of gene delivery and intracellular trafficking. Biointerphases. 2012; 7(1-4): 16.
11. Thrasher AJ, Gaspar HB, Baum C, Modlich U, Schambach A, Candotti F, Otsu M, Sorrentino B, Scobie L, Cameron E, Blyth K, Neil J, Abina SH, Cavazzana-Calvo M, Fischer A. Gene therapy: X-SCID transgene leukaemologenicity. Nature. 2006; 443(7109): E5-E6.
12. Zhang Y, Gao Y, Speth RC, Jiang N, Mao Y, Sumners C, Li H. Adenoviral and adeno-associated viral vectors-mediated neuronal gene transfer to cardiovascular control regions of the rat brain. Int J Med Sci. 2013; 10(5): 607-616.
13. Teramato S, Ishii T, Matsuse T. Crisis of adenoviruses in human gene therapy. Lancet. 2000; 355(9218): 1911-1912.
14. Okada H, Iizuka T, Mochizuki H, Nihira T, Kamiya K, Inoshita A, Kasagi H, Kasai M, Ikeda K. Gene transfer targeting mouse vestibule using adenovirus and adeno-associated virus vectors. Otol Neurotol. 2012; 33(4): 655-659.
15. Anson DS. The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector- mediated gene delivery. Genet Vaccines Ther. 2004; 2(1): 9.
16. Frederic D. Retroviral integration and human gene therapy. J Clin Invest. 2007; 117(8): 2083-2086.
17. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther.2001; 8(7): 551-556.
18. Real G, Monteiro F, Burger C, Alves PM. Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression. Appl Microbiol Biotechnol. 2011; 91(6): 1581-91.
19. Lachmann RH, Efstathiou S. The use of herpes simplex virus-based vectors for gene delivery to the nervous system. Mol Med Today. 1997; 3(9): 404-411.
20. Liu S, Dai M, You L, Zhao Y. Advance in herpes simplex viruses for cancer therapy. Sci China Life Sci. 2013; 56(4): 298-305.
21. Moss B. Reflections on the early development of poxvirus vectors. Vaccine. 2013; 31(39): 4220-4222.
22. Mulligan RC. The basic science of gene therapy. Science. 1993; 260: 926-932.
23. [No authors listed]. HIV vaccine failure prompts Merck to halt trial. Nature. 2007; 449(7161): 390.
24. Ledford H. HIV vaccine may raise risk. Nature. 2007; 450(7168): 325.
25. Sirsi SR, Borden MA. Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics. 2012; 2(12): 1208-1222.
26. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272(5259): 263-267.
27. Panje CM, Wang DS, Pysz MA, Paulmurugan R, Ren Y, Tranquart F, Tian L, Willmann JK. Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: Effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics. 2012; 2(11): 1078-1091.
28. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 1995; 2(10): 710-722.
29. Orio J, Coustets M, Mauroy C, Teissie J. Electric field orientation for gene delivery using high-voltage and low-voltage pulses. J Membr Biol. 2012; 245(10): 661-666.
30. Robinson HL, Pertmer TM. Nucleic acid immunizations. Curr Protoc Immunol. 2001; Chapter 2: Unit 2.14.
31. Vu L, Ramos J, Potta T, Rege K. Generation of a focused poly (amino ether) library: polymer-mediated transgene delivery and gold-nanorod based theranostic systems. Theranostics. 2012; 2(12): 1160-1173.
32. Khosravi-Darani K, Mozafari MR, Rashidi L, Mohammadi M. Calcium based non-viral gene delivery: an overview of methodology and applications. Acta Med Iranica. 2010; 48(3): 133-141.
33. Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release. 2008; 126(2): 97-110.
34. Yamano S, Dai J, Moursi AM. Comparison of transfection efficiency of nonviral gene transfer reagents. Mol Biotechnol. 2010; 46(3): 287-300.
35. Keifer OP Jr, O'Connor DM, Boulis NM. Gene and protein therapies utilizing VEGF for ALS. Pharmacol Ther. 2013; doi: 10.1016/j.pharmthera.2013.10.009.
36. Edmundson M, Thanh NT, Song B. Nanoparticles based stem cell tracking in regenerative medicine. Theranostics. 2013; 3(8): 573-582.
37. Li D, Liu S, Shan H, Conti P, Li Z. Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy. Theranostics. 2013; 3(7): 507-515.
38. Graham FL, Van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2): 456-467.
39. Orrantia E, Chang PL. Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp Cell Res. 1990; 190(2): 170-174.
40. Cao X, Deng W, Wei Y, Su W, Yang Y, Wei Y, Yu J, Xu X. Encapsulation of plasmid DNA in calcium phosphate nanoparticles: stem cell uptake and gene transfer efficiency. Int J Nanomedicine. 2011; 6: 3335-3349.
41. Hu J, Kovtun A, Tomaszewski A, Singer BB, Seitz B, Epple M, Steuhl KP, Ergün S, Fuchsluger TA. A new tool for the transfection of corneal endothelial cells: Calcium phosphate nanoparticles. Acta Biomater. 2012; 8(3): 1156-1163.
42. Kingston RE, Chen CA, Okayama H. Calcium phosphate transfection. Curr Protoc Immunol. 2001; Chapter 10:Unit 10.13.
43. Olton D, Li J, Wilson ME, Rogers T, Close J, Huang L, Kumta PN, Sfeir C. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials. 2007; 28(6): 1267-1279.
44. Sokolova V, Radtke I, Heumann R, Epple M. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials. 2006; 27(16): 3147-3153.
45. Pedraza CE, Bassett DC, McKee MD, Nelea V, Gbureck U, Barralet JE. The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials. 2008; 29(23): 3384-3392.
46. Elangovan S, Jain S, Tsai PC, Margolis HC, Amiji M. Nano-sized calcium phosphate particles for periodontal gene therapy. J Periodontol. 2013; 84(1): 117-125.
47. Nouri A, Castro R, Santos JL, Fernandes C, Rodrigues J, Tomäs H. Calcium phosphate-mediated gene delivery using simulated body fluid (SBF). Int J Pharm. 2012; 434(1-2): 199-208.
48. Bhakta G, Shrivastava A, and Maitra A. Magnesium phosphate nanoparticles can be efficiently used in vitro and in vivo as non-viral vectors for targeted gene delivery. J Biomed Nanotechnol. 2009; 5(1): 106-114.
49. Pezzoli D, Kajaste-Rudnitski A, Chiesa R, Candiani G. Lipid-based nanoparticles as nonviral gene delivery vectors. Methods Mol Biol. 2013; 1025: 269-279.
50. Zhi D, Zhang S, Wang B, Zhao Y, Yang B, Yu S. Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery. Bioconjug Chem. 2010; 21(4): 563-577.
51. Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, Wu G. Nomenclature for synthetic gene delivery systems. Hum Gene Ther. 1997; 8(5): 511-512.
52. Gao K, Huang L. Nonviral methods for siRNA delivery. Pharm. 2009; 6(3): 651-658.
53. Zelphati O, Nguyen C, Ferrari M, Felgner J, Tsai Y, Felgner PL. Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther. 1998; 5(9): 1272-1282.
54. Liu Y, Liggitt D, Zhong W, Tu G, Gaensler K, Debs R. Cationic liposome- mediated intravenous gene delivery. J Biol Chem. 1995; 42(270): 24864-24870.
55. Stewart MJ, Plautz GE, Del BL, Yang ZY, Xu L, Gao X, Huang L, Nabel EG, Nabel GJ. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther. 1992; 3(3): 267-275.
56. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 1993; 5118(261): 209-211.
57. Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovich P, Gallo RC, Mahan LC. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci U S A. 1995; 21(92): 9742-9746.
58. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev. 2009; 2(109): 259-302.
59. Bhattacharya S, Bajaj A. Advances in gene delivery through molecular design of cationic lipids. Chem Commun (Camb). 2009; 31: 4632-4656.
60. Martin B, Sainlos M, Aissaoui A, Oudrhiri N, Hauchecorne M, Vigneron JP, Lehn JM, Lehn P. The design of cationic lipids for gene delivery. Curr Pharm Des. 2005; 3(11): 375-394.
61. Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. Cationic lipid- mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta. 1998; 2(1368): 276-288.
62. Zelphati O, Uyechi LS, Barron LG, Szoka FJ. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta. 1998; 2(1390): 119-133.
63. Klein E, Ciobanu M, Klein J, Machi V, Leborgne C, Vandamme T, Frisch B, Pons F, Kichler A, Zuber G, Lebeau L. HFP fluorinated cationic lipids for enhanced lipoplex stability and gene delivery. Bioconjug Chem. 2010; 2(21): 360-371.
64. Mevel M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffres PA, Miller AD. Dodag; A versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. J Control Release. 2010; 2(143): 222-232.
65. Morille M, Montier T, Legras P, Carmoy N, Brodin P, Pitard B, Benoit JP, Passirani C. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials. 2010; 2(31): 321-329.
66. Zhi D, Zhang S, Wang B, Zhao Y, Yang B, Yu S. Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery. Bioconjug Chem. 2010; 4(21): 563-577.
67. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006; 1(114): 100-109.
68. Dobbs W, Heinrich B, Bourgogne C, Donnio B, Terazzi E, Bonnet ME, Stock F, Erbacher P, Bolcato-Bellemin AL, Douce L. Mesomorphic imidazolium salts: new vectors for efficient siRNA transfection. J Am Chem Soc. 2009; 37(131): 13338-13346.
69. Nie Y, Ji L, Ding H, Xie L, Li L, He B, Wu Y, Gu Z. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Theranostics. 2012; 2(11): 1092-1103.
70. Zhu L, Lu Y, Miller DD, Mahato RI. Structural and formulation factors influencing pyridinium lipid-based gene transfer. Bioconjug Chem. 2008; 12(19): 2499-2512.
71. Ahmad A, Evans HM, Ewert K, George CX, Samuel CE, Safinya CR. New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid-DNA complexes for gene delivery. J Gene Med. 2005; 6(7): 739-748.
72. Nie Y, Ji L, Ding H, Xie L, Li L, He B, Wu Y, Gu Z. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Theranostics. 2012; 2(11): 1092-1103.
73. Liberska A, Unciti-Broceta A, Bradley M. Very long-chain fatty tails for enhanced transfection. Org Biomol Chem. 2009; 7(1): 61-68.
74. Bajaj A, Kondiah P, Bhattacharya S. Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: a structure-activity investigation. J Med Chem. 2007; 50(10): 2432-2442.
75. Choi JS, Lee EJ, Jang HS, Park JS. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. Bioconjugate Chem. 2001; 1(12): 108-113.
76. Liu DL, Hu JJ, Qiao WH, Li ZS, Zhang SB, Cheng LB. Synthesis of carbamate- linked lipids for gene delivery. Bioorg Med Chem Lett. 2005; 12(15): 3147-3150.
77. Spelios M, Kearns M, Savva M. From gene delivery to gene silencing: plasmid DNA-transfecting cationic lipid 1,3-dimyristoylamidopropane-2-[bis(2-dimethylaminoethane)] carbamate efficiently promotes small interfering RNA-induced RNA interference. Biochemistry. 2010; 27(49): 5753-5759.
78. Yang HW, Yi JW, Bang EK, Jeon EM, Kim BH. Cationic nucleolipids as efficient siRNA carriers. Org Biomol Chem. 2011; 1(9): 291-296.
79. Li WJ, Szoka FC. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res. 2007; 3(24): 438-449.
80. Xu XZ, Tu L, Wang LY, Fang XS, Wang DW. CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats. Cardiovasc Diabetol. 2011; 10: 114.
81. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologicactivity, and lack of toxicity in humans. Proc Natl Acad Sci USA. 1993; 90(23): 11307-11311.
82. Leung SJ, Romanowski M. Light-activated content release from liposomes. Theranostics. 2012; 2(10): 1020-1036.
83. Zhang B, Ma XP, Murdoch W, Radosz M, Shen YQ. Bioreducible poly(amido amine)s with different branching degrees as gene delivery vectors. Biotechnol Bioeng. 2013; 3(110): 990-998.
84. Schaffert D, Troiber C, Wagner E. New sequence-defined polyaminoamides with tailored endosomolytic properties for plasmid DNA delivery. Bioconjugate Chem. 2012; 6(23): 1157-1165.
85. Li WB, Yuan W, Xu FJ, Zhao C, Ma J, Zhan QM. Functional study of dextran- graft-poly ((2-dimethyl amino) ethyl methacrylate) gene delivery vector for tumor therapy. J Biomater Appl. 2013; 28(1): 125-35.
86. Wang YQ, Su J, Wu F, Lu P, Yuan LF, Yuan WE, Sheng J, Jin T. Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int J Nanomedicine. 2012; 7: 693-704.
87. Zhou J, Liu J, Cheng CJ, Patel TR, Weller CE, Piepmeier JM, Jiang Z, Saltzman WM. Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater. 2012; 1(11): 82-90.
88. Choi JS, Nam K, Park JY, Kim JB, Lee JK, Park JS. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine. J Control Release. 2004; 3(99): 445-456.
89. Pfeifer BA, Burdick JA, Little SR, Langer R. Poly(ester-anhydride): poly(beta-amino ester) micro- and nanospheres: DNA encapsulation and cellular transfection. Int J Pharm. 2005; 304(1-2): 210-219.
90. Anderson DG, Akinc A, Hossain N, Langer R. Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther. 2005; 3(11): 426-434.
91. Hwang SJ, Bellocq NC, Davis ME. Effects of structure of beta- cyclodextrin-containing polymers on gene delivery. Bioconjugate Chem. 2001; 2(12): 280-290.
92. Kean T, Roth S, Thanou M. Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J Control Release. 2005; 3(103): 643-653.
93. Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials. 2002; 1(23): 153-159.
94. Bozkir A, Saka OM. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv. 2004; 2(11): 107-112.
95. Borchard G. Chitosans for gene delivery. Adv Drug Deliver Rev. 2001; 2(52): 145-150.
96. Chandy T, Sharma CP. Chitosan-as a biomaterial. Biomater Artif Cells Artif Organs. 1990; 1(18): 1-24.
97. Rinaudo M. Main properties and current applications of some polysaccharides as biomaterials. Polym Int. 2008; 3(57): 397-430.
98. Mourya VK, Inamdar NN. Chitosan-modifications and applications: opportunities galore. React Funct Polym. 2008; 6(68): 1013-1051.
99. Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther. 2006; 4(14): 476-484.
100. Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 2006; 27(27): 4815-4824.
101. He XK, Yuan ZX, Wu XJ, Xu CQ, Li WY. Low molecular weight hydroxyethyl chitosan-prednisolone conjugate for renal targeting therapy: synthesis, characterization and in vivo studies. Theranostics. 2012; 2(11): 1054-1063.
102. Prabaharan M, Mano JF. Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 2005; 1(12): 41-57.
103. Lai WF, Lin M. Nucleic acid delivery with chitosan and its derivatives. J Control Release. 2009; 3(134): 158-168.
104. Mao SR, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliver Rev. 2010; 1(62): 12-27.
105. Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials. 2001; 15(22): 2075-2080.
106. Turan K, Nagata K. Chitosan-DNA nanoparticles: the effect of cell type and hydrolysis of chitosan on in vitro DNA transfection. Pharm Dev Technol. 2006; 4(11): 503-512.
107. Sajomsang W, Gonil P, Ruktanonchai UR, Petchsangsai M, Opanasopit P, Puttipipatkhachorn S. Effects of molecular weight and pyridinium moiety on water-soluble chitosan derivatives for mediated gene delivery. Carbohyd Polym. 2013; 2(91): 508-517.
108. Sarkar K, Kundu PP. PAMAM conjugated chitosan through naphthalimide moiety for enhanced gene transfection efficiency. Carbohydr Polym. 2013; 98(1): 495-504.
109. Wang BQ, He CB, Tang C, Yin CH. Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers. Biomaterials. 2011; 20(32): 4630-4638.
110. Danielsen S, Strand S, Davies CD, Stokke BT. Glycosaminoglycan destabilization of DNA-chitosan polyplexes for gene delivery depends on chitosan chain length and GAG properties. Biochim Biophys Acta. 2005; 1721(1-3): 44-54.
111. Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. 2004; 1(57): 1-8.
112. Zhou XF, Zhang XH, Yu XH, Zha X, Fu Q, Liu B, Wan X, Chen Y, Chen Y, Shan YM, Jin YH, Wu YG, Liu JQ, Kong W, Shen JC. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials. 2008; 1(29): 111-117.
113. Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 2006; 27(27): 4815-4824.
114. Chae SY, Son S, Lee M, Jang MK, Nah JW. Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier. J Control Release. 2005; 109(1-3): 330-344.
115. Liu WG, Zhang X, Sun SJ, Sun GJ, De Yao K, Liang DC, Guo G, Zhang JY. N-alkylated chitosan as a potential nonviral vector for gene transfection. Bioconjugate Chem. 2003; 4(14): 782-789.
116. Lee D, Zhang W, Shirley SA, Kong X, Hellermann GR, Lockey RF, Mohapatra SS. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res. 2007; 1(24): 157-167.
117. Liu ZH, Zhang ZY, Zhou CR, Jiao YP. Hydrophobic modifications of cationic polymers for gene delivery. Prog Polym Sci. 2010; 9(35): 1144-1162.
118. Mao SR, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliver Rev. 2010; 1(62): 12-27.
119. Germershaus O, Mao SR, Sitterberg J, Bakowsky U, Kissel T. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. J Control Release. 2008; 2(125): 145-154.
120. Chan P, Kurisawa M, Chung JE, Yang YY. Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor- targeted gene delivery. Biomaterials. 2007; 3(28): 540-549.
121. Zhao X, Yin LC, Ding JY, Tang C, Gu SH, Yin CH, Mao YM. Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. J Control Release. 2010; 1(144): 46-54.
122. Zhou HF, Yu WT, Guo X, Liu XD, Li N, Zhang Y, Ma XJ. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin. Biomacromolecules. 2010; 12(11): 3480-3486.
123. Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 2006; 27(27): 4815-4824.
124. Nimesh S, Thibault MM, Lavertu M, Buschmann MD. Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum. Mol Biotechnol. 2010; 2(46): 182-196.
125. Thibault M, Nimesh S, Lavertu M, Buschmann MD. Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes. Mol Ther. 2010; 10(18): 1787-1795.
126. Masotti A, Bordi F, Ortaggi G, Marino F, Palocci C. A novel method to obtain chitosan/DNA nanospheres and a study of their release properties. Nanotechnology. 2008; 19(5): 055302.
127. Dai H, Jiang X, Tan GC, Chen Y, Torbenson M, Leong KW, Mao HQ. Chitosan- DNA nanoparticles delivered by intrabiliary infusion enhance liver- targeted gene delivery. Int. J. Nanomed. 2006; 4(1): 507-522.
128. Lee JI, Kim HS, Yoo HS. DNA nanogels composed of chitosan and pluronic with thermo-sensitive and photo-crosslinking properties. Int J Pharm. 2009; 373(1-2): 93-99.
129. Park SC, Nam JP, Kim YM, Kim JH, Nah JW, Jang MK. Branched polyethylenimine- grafted-carboxymethyl chitosan copolymer enhances the delivery of pDNA or siRNA in vitro and in vivo. Int J Nanomedicine. 2013; 8: 3663-77.
130. Liu CC, Zhu Q, Wu WH, Xu XL, Wang XY, Gao S, Liu KH. Degradable copolymer based on amphiphilic N-octyl-N-quatenary chitosan and low-molecular weight polyethylenimine for gene delivery. Int J Nanomed. 2012; 7: 5339-5350.
131. De Laporte L, Rea JC, Shea LD. Design of modular non-viral gene therapy vectors. Biomaterials. 2006; 7(27): 947-954.
132. Brown MD, Schatzlein AG, Uchegbu IF. Gene delivery with synthetic (non-viral) carriers. Int J Pharm. 2001; 229(1-2): 1-21.
133. Dai ZJ, Gjetting T, Mattebjerg MA, Wu C, Andresen TL. Elucidating the interplay between DNA-condensing and free polycations in gene transfection through a mechanistic study of linear and branched PEI. Biomaterials. 2011; 33(32): 8626-8634.
134. Nimesh S, Goyal A, Pawar V, Jayaraman S, Kumar P, Chandra R, Singh Y, Gupta KC. Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells. J Control Release. 2006; 110(2): 457-468.
135. Nimesh S, Aggarwal A, Kumar P, Singh Y, Gupta KC, Chandra R. Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles. Int J Pharm. 2007; 337(1-2): 265-274.
136. Vu L, Ramos J, Potta T, Rege K. Generation of a focused poly (amino ether) library: polymer-mediated transgene delivery and gold-nanorod based theranostic systems. Theranostics. 2012; 2(12): 1160-1173.
137. Boeckle S, von GersdorffK, van der Piepen S, Culmsee C, Wagner E, Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J Gene Med. 2004; 10(6): 1102-1111.
138. Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo polyethylenimine. Proc Natl Acad Sci U S A. 1995; 16(92): 7297-7301.
139. Zou SM, Erbacher P, Remy JS, Behr JP. Systemic linear polyethylenimine (l-PEI)-mediated gene delivery in the mouse. J Gene Med. 2000; 2(2): 128-134.
140. Fischer D, Bieber T, Li YX, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res. 1999; 8(16): 1273-1279.
141. Dunlap DD, Maggi A, Soria MR, Monaco L. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res. 1997; 15(25): 3095-3101.
142. Kawakami S, Ito Y, Charoensit P, Yamashita F, Hashida M. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J Pharmacol Exp Ther. 2006; 3(317): 1382-1390.
143. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther. 2005; 6(11): 990-995.
144. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release. 1999; 2-3(60): 149-160.
145. Thomas M, Klibanov AM. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biot. 2003; 1(62): 27-34.
146. Kunath K, von Harpe A, Fischer D, Peterson H, Bickel U, Voigt K, Kissel T. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release. 2003; 1(89): 113-125.
147. De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res. 2000; 2(17): 113-126.
148. Yang CA, Li HZ, Goh SH, Li J. Cationic star polymers consisting of alpha- cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors. Biomaterials. 2007; 21(28): 3245-3254.
149. Deng R, Yue Y, Jin F, Chen YC, Kung HF, Lin M, Wu C. Revisit the complexation of PEI and DNA-how to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure? J Control Release. 2009; 1(140): 40-46.
150. Merkel OM, Urbanics R, Bedocs P, Rozsnyay Z, Rosivall L, Toth M, Kissel T, Szebeni J. In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine- graft-poly(ethylene glycol) block copolymers. Biomaterials. 2011; 21(32): 4936-4942.
151. Fischer D, Bieber T, Li YX, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res. 1999; 8(16): 1273-1279.
152. Gosselin MA, Guo WJ, Lee RJ. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate Chem. 2001; 6(12): 989-994.
153. Breunig M, Lungwitz U, Liebl R, Goepferich A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci USA. 2007; 36(104): 14454-14459.
154. Breunig M, Lungwitz U, Liebl R, Goepferich A. Fluorescence resonance energy transfer: evaluation of the intracellular stability of polyplexes. Eur J Pharm Biopharm. 2006; 2(63): 156-165.
155. Choi S, Lee KD. Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release. 2008; 1(131): 70-76.
156. Deng R, Diao S, Yue YN, Ngai T, Wu C, Jin F. Dynamic and structural scalings of the complexation between pDNA and bPEI in semidilute and low-salt solutions. Biopolymers. 2010; 6(93): 571-577.
157. Peng Q, Zhong ZL, Zhuo RX. Disulfide cross-linked polyethylenimines (PEI) prepared via thiolation of low molecular weight PEI as highly efficient gene vectors. Bioconjugate Chem. 2008; 2(19): 499-506.
158. Knorr V, Ogris M, Wagner E. An acid sensitive ketal-based polyethylene glycol-oligoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity. Pharm Res. 2008; 12(25): 2937-2945.
159. Kloeckner J, Bruzzano S, Ogris M, Wagner E. Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties. Bioconjugate Chem. 2006; 5(17): 1339-1345.
160. Pathak A, Swami A, Patnaik S, Jain S, Chuttani K, Mishra AK, Vyas SP, Kumar P, Gupta KC. Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocomposites. J Biomed Nanotechnol. 2009; 3(5): 264-277.
161. Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem. 2003; 5(14): 934-940.
162. Lin C, Engbersen J. The role of the disulfide group in disulfide-based polymeric gene carriers. Expert. Opin. Drug Deliv. 2009; 4(6): 421-439.
163. Endres TK, Beck-Broichsitter M, Samsonova O, Renette T, Kissel TH. Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials. 2011; 30(32): 7721-7731.
164. Han SO, Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjugate Chem. 2001; 3(12): 337-345.
165. Lee M, Rentz J, Han SO, Bull DA, Kim SW. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther. 2003; 7(10): 585-593.
166. Aliabadi HM, Landry B, Bahadur RK, Neamnark A, Suwantong O, Uludag H. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers. Macromol Biosci. 2011; 5(11): 662-672.
167. Bahadur K, Landry B, Aliabadi HM, Lavasanifar A, Uludag H. Lipid substitution on low molecular weight (0.6-2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression. Acta Biomater. 2011; 5(7): 2209-2217.
168. Liu ZH, Zhang ZY, Zhou CR, Jiao YP. Hydrophobic modifications of cationic polymers for gene delivery. Prog Polym Sci. 2010; 9(35): 1144-1162.
169. Liu ZZ, Zheng M, Meng FH, Zhong ZY. Non-viral gene transfection in vitro using endosomal pH-sensitive reversibly hydrophobilized polyethylenimine. Biomaterials. 2011; 34(32): 9109-9119.
170. Mahato RI. Water insoluble and soluble lipids for gene delivery. Adv Drug Deliver Rev. 2005; 5(57): 699-712.
171. Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem. 2003; 5(14): 934-940.
172. Thomas M, Ge Q, Lu JJ, Chen JZ, Klibanov AM. Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res. 2005; 3(22): 373-380.
173. Liu TT, Yu XJ, Kan B, Guo QF, Wang XH, Shi SA, Guo G, Luo F, Zhao X, Wei YQ, Qian ZY. Enhanced gene delivery using biodegradable poly(ester amine)s (PEAs) based on low-molecular-weight polyethylenimine and poly(epsilon-caprolactone)-pluronic-poly(epsilon -caprolactone). J Biomed Nanotechnol. 2010; 4(6): 351-359.
174. Arote R, Kim TH, Kim YK, Hwang SK, Jiang HL, Song HH, Nah JW, Cho MH, Cho CS. A biodegradable poly(ester amine) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials. 2007; 4(28): 735-744.
175. Bauhuber S, Hozsa C, Breunig M, Gopferich A. Delivery of nucleic acids via disulfide-based carrier systems. Adv Mater. 2009; 21(32-33): 3286-3306.
176. Goyal R, Tripathi SK, Tyagi S, Ram KR, Ansari KM, Kumar P, Shukla Y, Chowdhuri DK, Gupta KC. Gellan gum-PEI nanocomposites as efficient gene delivery agents. J Biomed Nanotechnol. 2011; 7(1): 38-39.
177. Navarro G, de Ilarduya CT. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomedicine. 2009; 3(5): 287-297.
178. Wen YT, Guo ZH, Du Z, Fang R, Wu HM, Zeng X, Wang C, Feng M, Pan SR. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. Biomaterials. 2012; 32(33): 8111-8121.
179. Yin Z, Liu N, Ma MS, Wang L, Hao YL, Zhang XN. A novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimers. Int J Nanomedicine. 2012; 7: 4625-4635.
180. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release. 2000; 65(1-2): 133-148.
181. Han MH, Chen J, Wang J, Chen SL, Wang XT. In vivo delivery of Atoh1 gene to rat cochlea using a dendrimer-based nanocarrier. J Biomed Nanotechnol. 2013; 9(10): 1736-1745.
182. Cao D, Qin L, Huang H, Feng M, Pan S, Chen J. Transfection activity and the mechanism of pDNA-complexes based on the hybrid of low-generationPAMAM and branched PEI-1.8k. Mol Biosyst. 2013; 9(12): 3175-3186.
183. Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, Lacerda S, McNeil SE. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm. 2012; 3(9): 382-393.
184. Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol. 2002; 6(6): 742-748.
185. Lee CC, MacKay JA, Frechet J, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol. 2005; 12(23): 1517-1526.
186. Daneshvar N, Abdullah R, Shamsabadi FT, How CW, Aizat M, Mehrbod P. PAMAM dendrimer roles in gene delivery methods and stem cell research. Cell Biol Int. 2013; 5(37): 415-419.
187. KukowskaLatallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 1996; 10(93): 4897-4902.
188. Bielinska A, Kukowskalatallo J, Piehler LT, Yin R, Spindler R, Tomalia DA, Baker JR. Starburst(R) PAMAM dendrimers-a novel synthetic vector for the transfection of DNA into mammalian cells. Abstr Pap Am Chem Soc. 1995; 210(Part 2): 145.
189. Killops KL, Campos LM, Hawker CJ. Robust, efficient, and orthogonal synthesis of dendrimers via thiolene click chemistry. J Am Chem Soc. 2008; 15(130): 5062.
190. Shah N, Steptoe RJ, Parekh HS. Low-generation asymmetric dendrimers exhibit minimal toxicity and effectively complex DNA. J Pept Sci. 2011; 6(17): 470-478.
191. Pan SR, Cao DW, Huang H, Yi W, Qin LH, Feng M. A serum-resistant low-generation polyamidoamine with PEI 423 outer layer for gene delivery vector. Macromol Biosci. 2013; 4(13): 422-436.
192. Liu HM, Wang H, Yang WJ, Cheng YY. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. J Am Chem Soc. 2012; 42(134): 17680-17687.
193. Nakhlband A, Barar J, Bidmeshkipour A, Heidari HR, Omidi Y. Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells. J Biomed Nanotechnol. 2010; 4(6): 360-369.
194. Kim JB, Choi JS, Nam K, Lee M, Park JS, Lee JK. Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-arg. J Control Release. 2006; 1(114): 110-117.
195. Santos JL, Oliveira H, Pandita D, Rodrigues J, Pego AP, Granja PL, Tomas H. Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J Control Release. 2010; 1(144): 55-64.
196. Luo K, Li CX, Li L, She WC, Wang G, Gu ZW. Arginine functionalized peptide dendrimers as potential gene delivery vehicles. Biomaterials. 2012; 19(33): 4917-4927.
197. Nam HY, Nam K, Hahn HJ, Kim BH, Lim HJ, Kim HJ, Choi JS, Park JS. Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity. Biomaterials. 2009; 4(30): 665-673.
198. Kono K, Akiyama H, Takahashi T, Takagishi T, Harada A. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconjugate Chem. 2005; 1(16): 208-214.
199. Sanclimens G, Shen H, Giralt E, Albericio F, Saltzman MW, Royo M. Synthesis and screening of a small library of proline-based biodendrimers for use as delivery agents. Biopolymers. 2005; 6(80): 800-814.
200. Kang CS, Yuan XB, Li F, Pu PY, Yu SZ, Shen CH, Zhang ZY, Zhang YT. Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo. J Biomed Mater Res. 2010; 2(93A): 585-594.
201. Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, Uekama K. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. J Control Release. 2005; 2(104): 397-413.
202. Arima H, Yamashita S, Mori Y, Hayashi Y, Motoyama K, Hattori K, Takeuchi T, Jono H, Ando Y, Hirayama F, Uekama K. In vitro and in vivo gene delivery mediated by lactosylated dendrimer/alpha-cyclodextrin conjugates (g2) into hepatocytes. J Control Release. 2010; 1(146): 106-117.
203. Wada K, Arima H, Tsutsumi T, Hirayama F, Uekama K. Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency. Biol Pharm Bull. 2005; 3(28): 500-505.
204. Zhang Q, Chen S, Zhuo RX, Zhang XZ, Cheng SX. Self-assembled terplexes for targeted gene delivery with improved transfection. Bioconjugate Chem. 2010; 11(21): 2086-2092.
205. Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol- modified polyamidoamine dendrimer. Faseb J. 2007; 4(21): 1117-1125.
206. Han LA, Huang RQ, Li JF, Liu SH, Huang SX, Jiang C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials. 2011; 4(32): 1242-1252.
207. Cui DX, Huang P, Zhang CL, Ozkan CS, Pan BF, Xu P. Dendrimer-modified gold nanorods as efficient controlled gene delivery system under near-infrared light irradiation. J Control Release. 2011; 152Suppl1: E137-E139.
208. Shan YB, Luo T, Peng C, Sheng RL, Cao AM, Cao XY, Shen MW, Guo R, Tomas H, Shi XY. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials. 2012; 10(33): 3025-3035.
209. Herrero MA, Toma FM, Al-Jamal KT, Kostarelos K, Bianco A, Da Ros T, Bano F, Casalis L, Scoles G, Prato M. Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. J Am Chem Soc. 2009; 28(131): 9843-9848.
210. Breunig M, Lungwitz U, Liebl R, Goepferich A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci U S A. 2007; 36(104): 14454-14459.
211. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin. Bioconjugate Chem. 2002; 6(13): 1211-1219.
212. Lee JH, Lim YB, Choi JS, Lee Y, Kim TI, Kim HJ, Yoon JK, Kim K, Park JS. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjugate Chem. 2003; 6(14): 1214-1221.
213. Patil ML, Zhang M, Betigeri S, Taratula O, He H, Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjugate Chem. 2008; 7(19): 1396-1403.
214. Sun XL, Zhang N. Cationic polymer optimization for efficient gene delivery. Mini. Rev. Med. Chem. 2010; 2(10): 108-125.
215. Zhou JH, Wu JY, Hafdi N, Behr JP, Erbacher P, Peng L. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun. 2006; (22): 2362-2364.
216. Aydin Z, Akbas F, Senel M, Koc SN. Evaluation of Jeffamine®-cored PAMAM dendrimers as an efficient in vitro gene delivery system. J Biomed Mater Res A. 2012; 10(100): 2623-2628.
217. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem. 1996; 6(7): 703-714.
218. Bhakta G, Shrivastava A, Maitra A. Magnesium phosphate nanoparticles can be efficiently used in vitro and in vivo as non-viral vectors for targeted gene delivery. J. Biomed. Nanotechnol. 2009; 1(5): 106-114.
219. Langer R. Drug delivery and targeting. Nature. 1998; 392(6679 Suppl): 5-10.
220. Pedone E, Cavallaro G, Richardson S, Duncan R, Giammona G. Alpha, beta- poly(asparthylhydrazide)-glycidyltrimethylammonium chloride copolymers (PAHy-GTA): novel polymers with potential for DNA delivery. J Control Release. 2001; 77(1-2): 139-153.
221. Kang HC, Lee M, Bae YH. Polymeric gene carriers. Crit Rev Eukar Gene. 2005; 4(15): 317-342.
222. Chemin I, Moradpour D, Wieland S, Offensperger WB, Walter E, Behr JP, Blum HE. Liver-directed gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepatitis. 1998; 6(5): 369-375.
223. Blum JS, Saltzman WM. High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-l-lysine. J Control Release. 2008; 1(129): 66-72.
224. Shah B, Kona S, Gilbertson TA, Nguyen KT. Effects of poly-(lactide-co-glycolide) nanoparticles on electrophysiological properties of enteroendocrine cells. J Nanosci Nanotechnol. 2011; 11(4): 3533-3542.
225. Hedley ML. Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors. Expert Opin Biol Th. 2003; 6(3): 903-910.
226. Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Release. 2001; 76(1-2): 149-168.
227. Wang DQ, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(d, l-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Control Release. 1999; 1(57): 9-18.
228. Denis-Mize KS, Dupuis M, Singh M, Woo C, Ugozzoli M, O'Hagan DT, Donnelly JJ, Ott G, McDonald DM. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. Cell Immunol. 2003; 1(225): 12-20.
229. He XW, Jiang L, Wang F, Xiao ZY, Li J, Liu LS, Li D, Ren D, Jin XQ, Li K, He Y, Shi K, Guo YJ, Zhang YN, Sun SH. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles. J Control Release. 2005; 2(107): 357-372.
230. He XW, Wang F, Jiang L, Li J, Liu SK, Xiao ZY, Jin XQ, Zhang YN, He Y, Li K, Guo YJ, Sun SH. Induction of mucosal and systemic immune response by single- dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol. 2005; 3(86): 601-610.
231. Lima KM, Santos SA, Lima V, Coelho-Castelo A, Rodrigues JM, Silva CL. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of mycobacterium tuberculosis. Gene Ther. 2003; 8(10): 678-685.
232. Coelho E, Tavares C, Lima KD, Silva CL, Rodrigues JM, Fernandes AP. Mycobacterium hsp65 DNA entrapped into TMD-loaded PLGA microspheres induces protection in mice against leishmania (leishmania) major infection. Parasitol Res. 2006; 6(98): 568-575.
233. Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit Rev Ther Drug. 2005; 5(22): 419-463.
234. Kumar M, Mohapatra SS, Kong X, Jena PK, Bakowsky U, Lehr CM. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J Nanosci Nanotechnol. 2004; 8(4): 990-994.
235. Walter E, Moelling K, Pavlovic J, Merkle HP. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics. J Control Release. 1999; 3(61): 361-374.
236. Zhu GZ, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat Biotechnol. 2000; 1(18): 52-57.
237. Li YP, Ogris M, Pelisek J, Roedl W. Stability and release characteristics of poly(d, l-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation. Int J Pharm. 2004; 1(269): 61-70.
238. Aral C, Akbuga J. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA: poly(l-lysine) complexes. J Pharm Pharm Sci. 2003; 3(6): 321-326.
239. Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH. Formulation of poly(d, l-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Control Release. 2000; 66(2-3): 229-241.
240. Orrantia E, Chang PL. Intracellular-distribution of DNA internalized through calcium-phosphate precipitation. Exp Cell Res. 1990; 2(190): 170-174.
241. Loyter A, Scangos G, Juricek D, Keene D, Ruddle FH. Mechanisms of DNA entry into mammalian cells. II. Phagocytosis of calcium phosphate DNA co-precipitate visualized by electron microscopy. Exp Cell Res. 1982; 1(139): 223-234.
242. Zauner W, Farrow NA, Haines A. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release. 2001; 1(71): 39-51.
243. Tang J, Chen JY, Liu J, Luo M, Wang YJ, Wei XW, Gao X, Wang BL, Liu YB, Yi T, Tong AP, Song XR, Xie YM, Zhao YL, Xiang ML, Huang Y, Zheng Y. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency. Int J Pharm. 2012; 431(1-2): 210-221.
244. Shau MD, Shih MF, Lin CC, Chuang IC, Hung WC, Hennink WE, Cherng JY. A one-step process in preparation of cationic nanoparticles with poly(lactide-co-glycolide)-containing polyethylenimine gives efficient gene delivery. Eur J Pharm Sci. 2012; 5(46): 522-529.
245. Zeng P, Xu Y, Zeng CH, Ren H, Peng ML. Chitosan-modified poly(d, l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int J Pharm. 2011; 415(1-2): 259-266.
246. Ramsay E, Gumbleton M. Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency. J Drug Target. 2002; 1(10): 1-9.
247. Balicki D, Putnam CD, Scaria PV, Beutler E. Structure and function correlation in histone H2A peptide-mediated gene transfer. Proc Natl Acad Sci U S A. 2002; 11(99): 7467-7471.
248. Park YJ, Liang JF, Ko KS, Kim SW, Yang VC. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J Gene Med. 2003; 8(5): 700-711.
249. Wang J, Mao HQ, Leong KW. A novel biodegradable gene carrier based on polyphosphoester. J Am Chem Soc. 2001; 38(123): 9480-9481.
250. Ping Y, Wu D, Kumar JN, Cheng W, Lay CL, Liu Y. Redox-responsive hyperbranched poly(amido amine)s with tertiary amino cores for gene delivery. Biomacromolecules. 2013; 6(14): 2083-2094.
251. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem. 1987; 10(262): 4429-4432.
252. Wagner E, Cotten M, Foisner R, Birnstiel ML. Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci U S A. 1991; 10(88): 4255-4259.
253. Emmrich S, Wang W, John K, Li W, Putzer BM. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. Mol Cancer. 2009; 8: 61.
254. Thiersch M, Rimann M, Panagiotopoulou V, Öztürk E, Biedermann T, Textor M, Lühmann TC, Hall H. The angiogenic response to PLL-g-PEG-mediated HIF-1a plasmid DNA delivery in healthy and diabetic rats. Biomaterials. 2013; 34(16): 4173-4182.
255. Asparuhova MB, Barde I, Trono D, Schranz K, Schumperli D. Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication. J Gene Med. 2008; 10(10): 1059-1070.
256. Deng J, Gao N, Wang Y, Yi H, Fang S, Ma Y, Cai L. Self-assembled cationic micelles based on PEG-PLL-PLLeu hybrid polypeptides as highly effective gene vectors. Biomacromolecules. 2012; 13(11): 3795-3804.
257. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials. 2008; 29(24-25): 3477-3496.
258. Cutroneo KR. Gene therapy for tissue regeneration. J Cell Biochem. 2003; 2(88): 418-425.
259. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci U S A. 1990; 9(87): 3410-3414.
260. Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. Transfection of folate- polylysine DNA complexes: evidence for lysosomal delivery. Bioconjug Chem. 1995; 5(6): 512-515.
261. Schachtschabel U, Pavlinkova G, Lou D, Kohler H. Antibody-mediated gene delivery for B-cell lymphoma in vitro. Cancer Gene Ther. 1996; 6(3): 365-372.
262. Sosnowski BA, Gonzalez AM, Chandler LA, Buechler YJ, Pierce GF, Baird A. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J Biol Chem. 1996; 52(271): 33647-33653.
263. Samson SL, Gonzalez EV, Yechoor V, Bajaj M, Oka K, Chan L. Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model. Mol Ther. 2008; 11(16): 1805-1812.
264. Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, Aebischer P, Svendsen CN. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods. 2007; 2(163): 338-349.
265. Okumura K, Nakase M, Nakamura S, Kamei T, Inui M, Tagawa T. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo. Oncol Rep. 2007; 4(17): 769-773.
266. Yoo H, Moon SK, Hwang T, Kim YS, Kim JH, Choi SW, Kim JH. Multifunctional magnetic nanoparticles modified with polyethylenimine and folic acid for biomedical theranostics. Langmuir. 2013; 29(20): 5962-5967.
267. Kono K, Ikeda R, Tsukamoto K, Yuba E, Kojima C, Harada A. Polyamidoamine dendron-bearing lipids as a nonviral vector: influence of dendron generation. Bioconjug Chem. 2012; 4(23): 871-879.
268. Zhou C, Yu B, Yang X, Huo T, Lee LJ, Barth RF, Lee RJ. Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm. 2010; 392(1-2): 201-208.
269. Jiang M, Gan L, Zhu C, Dong Y, Liu J, Gan Y. Cationic core-shell liponanoparticles for ocular gene delivery. Biomaterials. 2012; 30(33): 7621-7630.
270. Vu L, Ramos J, Potta T, Rege K. Generation of a focused poly(amino ether) library: polymer-mediated transgene delivery and gold-nanorod based theranostic systems. Theranostics. 2012; 2(12): 1160-1173.
271. Luk BT, Fang RH, Zhang L. Lipid- and polymer-based nanostructures for cancer theranostics. Theranostics. 2012; 2(12): 1117-1126.
272. Guo Y, Liu X, Sun X, Zhang Q, Gong T, Zhang Z. Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery. Theranostics. 2012; 2(11): 1104-1114.
273. Yaghoubi SS, Campbell DO, Radu CG, Czernin J. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics. 2012; 2(4): 374-391.
274. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharm Ther. 2008; 83: 761-769.
275. Sokolova V, Epple M. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed Engl. 2008; 8(47): 1382-1395.
276. Hafeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, Dailey JP, Bardenstein D. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm. 2009; 5(6): 1417-1428.
277. Panje CM, Wang DS, Pysz MA, Paulmurugan R, Ren Y, Tranquart F, Tian L, Willmann JK. Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics. 2012; 2(11): 1078-1091.
278. Kittler S, Greulich C, Diendorf J, Koller M, Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater. 2010; 16(22): 4548-4554.
279. Wang C, Cheng L, Liu Z. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics. 2013; 3(5): 317-330.
280. Neumann S, Kovtun A, Dietzel ID, Epple M, Heumann R. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection. Biomaterials. 2009; 35(30): 6794-6802.
281. Kubinova S, Sykova E. Nanotechnologies in regenerative medicine. Minim Invasive Ther Allied Technol. 2010; 3(19): 144-156.
282. Raffa V, Vittorio O, Riggio C, Cuschieri A. Progress in nanotechnology for healthcare. Minim Invasive Ther Allied Technol. 2010; 3(19): 127-135.